US Medication Risk Evaluation and Mitigation Strategies (REMS) FHIR IG
2.0.0-ballot - STU 2 Ballot

US Medication Risk Evaluation and Mitigation Strategies (REMS) FHIR IG, published by HL7 International / Pharmacy. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-medication-rems-ig/ and changes regularly. See the Directory of published versions

## Credits

This Implementation Guide is the result of the efforts of the CodeX REMS Integration Use Case, with the support and active participation of the following participants:

- AbbVie
- APCER
- Bristol Meyers Squibb
- InfoWerks
- Invaryant
- Lamics
- MITRE
- NCPDP
- Otsuka
- Point-of-Care Partners
- Prescryptive
- REMS Industry Consortium (RIC)
- Syneos
- UBC
- US Food and Drug Administration (FDA)

Our thanks to these organizations and to the individuals not explicitly listed who contributed their time, enthusiasm and expertise to this work.